IGF-1 (mecasermin) clinical trials: 25 trials
Page 1 of 1
Read 25 IGF-1 (mecasermin) clinical trials with posted results or linked papers with results in PepBank.
- Assessment of Mechanisms of Improved Wound Healing
NCT00673309 · Phase 2/3 · Completed
Posted results
- Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial
NCT00035815 · Phase 3 · Completed
Posted results
- Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
NCT00125164 · Phase 3 · Completed
Posted results
- Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency
NCT00330668 · Phase 3 · Terminated
Posted results
- Long-Term Treatment With rhIGF-1 in GHIS
NCT00571727 · Phase 2/3 · Completed
Posted results
- Effects of Anorexia Nervosa on Peak Bone Mass
NCT01301183 · Phase 3 · Completed
Posted results
- Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
NCT00125190 · Phase 2/3 · Completed
Posted results
- Effect of Increlex® on Children With Crohn Disease
NCT00764699 · Phase 2/3 · Terminated
Posted results
- IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
NCT01096784 · Phase 2 · Completed
Posted results
- rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
NCT00572156 · Phase 2 · Terminated
Posted results
- Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
NCT02386839 · Phase 2 · Completed
Posted results
- Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
NCT00577577 · Phase 2 · Completed
Posted results
- Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
NCT01207908 · Phase 1/2 · Completed
Posted results
- Treatment of Rett Syndrome With Recombinant Human IGF-1
NCT01777542 · Phase 2 · Completed
Posted results
- Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
NCT00720122 · Phase 2 · Completed
Posted results
- Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
NCT01525901 · Phase 2 · Completed
Posted results
- Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents
NCT00516386 · Phase 1/2 · Completed
Posted results
- Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma
NCT03041701 · Phase 1/2 · Terminated
Posted results
- IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency
NCT02636270 · Phase 1/2 · Completed
Posted results
- Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
NCT00490100 · Phase 1/2 · Terminated
Posted results
- Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
NCT00684957 · Phase 1/2 · Terminated
Posted results
- A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
NCT01970345 · Phase 2 · Terminated
Posted results
- A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263 · Phase 2 · Active, not recruiting
Linked paper with results
- Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)
NCT01253317 · Phase 1 · Completed
Posted results
- IGF-1 and Bone Loss in Women With Anorexia Nervosa
NCT01406444 · Not applicable · Completed
Posted results